Viewing Study NCT04211168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-01-27 @ 5:04 AM
Study NCT ID: NCT04211168
Status: UNKNOWN
Last Update Posted: 2023-03-29
First Post: 2019-12-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Sponsor: Peking Union Medical College Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Intrahepatic cholangiocarcinoma View
None hilar cholangiocarcinoma View
None common bile duct cancer View
None gallbladder cancer View
None Toripalimab View
None Lenvatinib View
None biomarker View